(Q47831840)

English

Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients

scientific article published in February 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gerd-Rüdiger Burmester

5

object named as

G R Burmester

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

author name string

B E Reiche

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

S Ohrndorf

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

E Feist

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

J Messerschmidt

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

M Backhaus

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

publication date

1 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

Arthritis Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

66

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

204-216

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Prospective 7 year follow up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger joints

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Consensus statement on the use of rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Guidelines for musculoskeletal ultrasound in rheumatology

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Settings and artefacts relevant in colour/power Doppler ultrasound in rheumatology

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: A pilot project

1 reference

https://api.crossref.org/works/10.1002%2FACR.22103

21 January 2018

Identifiers

10.1002/ACR.22103

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/23925935

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47831840&oldid=2172250083"